Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
28 Fevereiro 2024 - 10:30AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage
biotechnology company focused on unlocking the broad potential of
RNA medicines to transform human health, will host a live webcast
and conference call at 8:30 a.m. ET on Wednesday, March 6, 2024, to
review the company’s fourth quarter and full year 2023 financial
results and provide business updates.
The webcast and conference call may be accessed by visiting
“Investor Events” on the investors section of the Wave Life
Sciences website:
ir.wavelifesciences.com/events-publications/events.
Analysts planning to participate during the Q&A portion of
the live call can join the conference call at the following audio
conferencing link: available here. Once registered, participants
will receive the dial-in information.
Following the live event, an archived version of the webcast
will be available on the Wave Life Sciences website.
About Wave Life SciencesWave Life Sciences
(Nasdaq: WVE) is a biotechnology company focused on unlocking the
broad potential of RNA medicines to transform human health. Wave’s
RNA medicines platform, PRISMTM, combines multiple modalities,
chemistry innovation and deep insights in human genetics to deliver
scientific breakthroughs that treat both rare and prevalent
disorders. Its toolkit of RNA-targeting modalities includes
editing, splicing, RNA interference and antisense silencing,
providing Wave with unmatched capabilities for designing and
sustainably delivering candidates that optimally address disease
biology. Wave’s diversified pipeline includes clinical programs in
Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and
Huntington’s disease, as well as a preclinical program in obesity.
Driven by the calling to “Reimagine Possible”, Wave is leading the
charge toward a world in which human potential is no longer
hindered by the burden of disease. Wave is headquartered in
Cambridge, MA. For more information on Wave’s science, pipeline,
and people, please visit www.wavelifesciences.com and follow Wave
on X (formerly Twitter) and LinkedIn.
Investor Contact:Kate Rausch+1
617-949-4827krausch@wavelifesci.com
Media Contact:Alicia Suter+1
617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Wave Life Sciences (NASDAQ:WVE)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024